Literature DB >> 17905742

Low utilization of circulating glucose after food withdrawal in Snell dwarf mice.

Natasha L Brooks1, Chad M Trent, Carl F Raetzsch, Kevin Flurkey, Gunnar Boysen, Michael T Perfetti, Yo-Chan Jeong, Simon Klebanov, Kajal B Patel, Valerie R Khodush, Lawrence L Kupper, David Carling, James A Swenberg, David E Harrison, Terry P Combs.   

Abstract

Glucose metabolism is altered in long-lived people and mice. Although it is clear that there is an association between altered glucose metabolism and longevity, it is not known whether this link is causal or not. Our current hypothesis is that decreased fasting glucose utilization may increase longevity by reducing oxygen radical production, a potential cause of aging. We observed that whole body fasting glucose utilization was lower in the Snell dwarf, a long-lived mutant mouse. Whole body fasting glucose utilization may be reduced by a decrease in the production of circulating glucose. Our isotope labeling analysis indicated both gluconeogenesis and glycogenolysis were suppressed in Snell dwarfs. Elevated circulating adiponectin may contribute to the reduction of glucose production in Snell dwarfs. Adiponectin lowered the appearance of glucose in the media over hepatoma cells by suppressing gluconeogenesis and glycogenolysis. The suppression of glucose production by adiponectin in vitro depended on AMP-activated protein kinase, a cell mediator of fatty acid oxidation. Elevated fatty acid oxidation was indicated in Snell dwarfs by increased utilization of circulating oleic acid, reduced intracellular triglyceride content, and increased phosphorylation of acetyl-CoA carboxylase. Finally, protein carbonyl content, a marker of oxygen radical damage, was decreased in Snell dwarfs. The correlation between high glucose utilization and elevated oxygen radical production was also observed in vitro by altering the concentrations of glucose and fatty acids in the media or pharmacologic inhibition of glucose and fatty acid oxidation with 4-hydroxycyanocinnamic acid and etomoxir, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905742     DOI: 10.1074/jbc.M700484200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.

Authors:  Carl F Raetzsch; Natasha L Brooks; J McKee Alderman; Kelli S Moore; Peter A Hosick; Simon Klebanov; Shizuo Akira; James E Bear; Albert S Baldwin; Nigel Mackman; Terry P Combs
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

2.  Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

Authors:  J McKee Alderman; Kevin Flurkey; Natasha L Brooks; Sneha B Naik; Jonathan M Gutierrez; Urmila Srinivas; Kristen B Ziara; Linhong Jing; Gunnar Boysen; Rod Bronson; Simon Klebanov; Xian Chen; James A Swenberg; Mats Stridsberg; Carol E Parker; David E Harrison; Terry P Combs
Journal:  Exp Gerontol       Date:  2008-06-07       Impact factor: 4.032

Review 3.  Role of the hypothalamus in mediating protective effects of dietary restriction during aging.

Authors:  Penny A Dacks; Cesar L Moreno; Esther S Kim; Bridget K Marcellino; Charles V Mobbs
Journal:  Front Neuroendocrinol       Date:  2012-12-20       Impact factor: 8.606

4.  Adiponectin lowers glucose production by increasing SOGA.

Authors:  Rachael B Cowherd; Rachael B Cowerd; Melissa M Asmar; J McKee Alderman; Elizabeth A Alderman; Alaina L Garland; Walker H Busby; Wanda M Bodnar; Ivan Rusyn; Benjamin D Medoff; Roland Tisch; Elizabeth Mayer-Davis; James A Swenberg; Steven H Zeisel; Terry P Combs
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

5.  Metabolic mystery: aging, obesity, diabetes, and the ventromedial hypothalamus.

Authors:  Charles V Mobbs; Cesar L Moreno; Michael Poplawski
Journal:  Trends Endocrinol Metab       Date:  2013-06-20       Impact factor: 12.015

Review 6.  GH and IGF1: roles in energy metabolism of long-living GH mutant mice.

Authors:  Holly M Brown-Borg; Andrzej Bartke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-30       Impact factor: 6.053

Review 7.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 8.  Hormonal control of aging in rodents: the somatotropic axis.

Authors:  Holly M Brown-Borg
Journal:  Mol Cell Endocrinol       Date:  2008-07-11       Impact factor: 4.102

Review 9.  Adiponectin signaling in the liver.

Authors:  Terry P Combs; Errol B Marliss
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

Review 10.  The GH/IGF-1 axis in ageing and longevity.

Authors:  Riia K Junnila; John J Kopchick; Edward O List; Darlene E Berryman; John W Murrey
Journal:  Nat Rev Endocrinol       Date:  2013-04-16       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.